A detailed history of Fortis Group Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 3,486 shares of PFE stock, worth $95,725. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,486
Previous 3,486 -0.0%
Holding current value
$95,725
Previous $97.5 Million 3.43%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $90,252 - $103,638
-3,486 Reduced 50.0%
3,486 $96.7 Million
Q4 2023

Mar 04, 2024

BUY
$26.13 - $33.94 $91,089 - $118,314
3,486 Added 100.0%
6,972 $201 Million
Q3 2023

Dec 01, 2023

BUY
$32.09 - $37.51 $111,865 - $130,759
3,486 New
3,486 $116 Million
Q1 2023

May 26, 2023

SELL
$39.39 - $51.28 $502,458 - $654,127
-12,756 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$31.75 - $37.25 $405,003 - $475,161
12,756 New
12,756 $467,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.